Search





Search





Markets
/
Stocks
/
nasdaq-trax
/

First Tracks Biotherapeutics Ord Shs

TRAX

Add to Watchlist

15.835USD

-0.135-0.84%

Market hours （ET）Quotes delayed by 15 min

550.25MMarket Cap

--P/E TTM



First Tracks Biotherapeutics Ord Shs

15.835

-0.135-0.84%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of First Tracks Biotherapeutics Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---32.56M

Net income from continuing operations

---50.48M

Operating gains losses

--125.00K

Other non-cash items

--0.00

Change in working capital

--6.30M

-Change in prepaid expenses

--2.16M

-Change in payables and accrued expense

--4.15M

Cash from non-recurring investing activities

Cash from operating activities

---32.56M

Investing cash flow

Net cash from continuing investing activities

--17.00K

Capital expenditures

--17.00K

Net cash flow from disposal of fixed assets

--17.00K

Net cash flow from investment products

--35.00M

Net cash flow from other investing activities

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

--34.98M

Financing cash flow

Cash flow from continuous financing activities

--7.85M

Net cash flow from common stock issuance/repurchase

--7.85M

Net cash flow from other financing activities

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

--7.85M

Net cash flow

Beginning cash balance

--238.20M

Current period cash flow changes

--10.27M

Ending cash balance

--248.47M

Free cash flow

---32.58M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

